Questions about pharmacies or tracking?
Email krewe@joinbigeasy.com or call (504) 313-6301
503(b) Pharmacies
FDA-registered outsourcing facilities held to the highest manufacturing standards (cGMP)
BPI Labs
BPI is an FDA-registered 503(b) outsourcing facility held to cGMP standards (21 CFR 210/211). Shipped through intermediary pharmacy partner.
Medivant
Medivant is an FDA-registered 503(b) facility providing pre-filled glass syringes packaged in a sterile environment. Unlike vials, Medivant’s format offers convenient, precise dosing.
ProRx
ProRx is an FDA-registered 503(b) outsourcing facility offering extended beyond-use dates (BUDs) up to 120 days.
503(a) Pharmacies
State board-regulated compounding pharmacies offering personalized formulations
OptioRx
Phone: 773-549-0634, option 3
OptioRx operates a network of pharmacies including SBH, Enovex, and Braun, allowing for flexible fulfillment and faster turnaround times.
Hallandale Pharmacy
Hallandale is a well-established Florida-based compounding pharmacy with decades of experience in custom pharmaceutical preparations.
Miller's Pharmacy
Miller’s is a trusted compounding pharmacy offering personalized medication formulations.
Seven Cells
Seven Cells specializes in compounded GLP-1 and regenerative medicine formulations.
Understanding 503(a) vs 503(b)

503(b) Pharmacies
FDA-registered outsourcing facilities held to the same manufacturing standards as brand-name drug manufacturers (cGMP). They undergo regular FDA inspections, and their products have verified beyond-use dates supported by stability testing. There are only about 90 503(b)s in the US.
503(a) Pharmacies
Traditional compounding pharmacies regulated by state boards of pharmacy. They offer more flexibility for personalized formulations but have varying standards depending on state regulations. There are approximately 12,000 503(a)s in the US.
Both types of pharmacies we work with are fully licensed and legally permitted to compound medications. Your Big Easy physician will help determine which pharmacy is the best fit for your treatment plan.
For more details, see our FAQ section on 503(a) vs 503(b).
Meet Our Team of Providers
Meet Our Team

Dr. Gabriel Lasala
Chief Medical Officer (CMO)

P. David Soliman
Chief Executive Officer (CEO)

Marcia Katheryn Webb
Chief Operational Officer (COO)

Michelle Keyes Soliman
Chief Marketing Officer (CMO)











